Patent Expiry

Patent/Exclusivity Expiry: KHAPZORY

March 25, 2039

Company: Tango Therapeutics, Inc. (TNGX)
Drug: KHAPZORY

Other upcoming events for TNGX

Phase 3 ReadoutPhase 3 Topline: A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of A

Patent ExpiryPatent/Exclusivity Expiry: VYKOURA

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Patent/Exclusivity Expiry: KHAPZORY — TNGX Patent Expiry | BioSniper